Corneal Perforation in a Patient Treated with Atezolizumab-Bevacizumab Combination Therapy for Unresectable Hepatocellular Carcinoma

Majed S. Alkharashi; Rakan S. Al-Essa; Wael Otaif; Ibrahim Algorashi

doi:10.12659/AJCR.940688

01 September 2023 : Case report Saudi Arabia

Corneal Perforation in a Patient Treated with Atezolizumab-Bevacizumab Combination Therapy for Unresectable Hepatocellular Carcinoma

Unusual or unexpected effect of treatment, Rare disease, Adverse events of drug therapy

Majed S. Alkharashi^1AE, Rakan S. Al-Essa^2ABCDEF*, Wael Otaif^123ABEF, Ibrahim Algorashi^4AD

DOI: 10.12659/AJCR.940688

Am J Case Rep 2023; 24:e940688

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

View HTML version

Figure 1. (A) Slit-lamp clinical photo of the right eye showing severe ocular surface disease. (B) Slit-lamp clinical photo of the left eye showing a paracentral, punched out, sterile corneal perforation.

Back to the Article

Corneal Perforation in a Patient Treated with Atezolizumab-Bevacizumab Combination Therapy for Unresectable Hepatocellular Carcinoma

Your Privacy